Updates

12
Apr

A review describing the basic aspects, practical measurements and clinical applications of coronary endothelial function using myocardial perfusion PET in subjects with various coronary risk factors has been published online March 30 in the Journal of Nuclear Cardiology.

Endothelial dysfunction is the earliest... Read More

01
Apr

Cardiovascular Business Magazine

Positron’s Attrius PET System is highlighted in the April edition of Cardiovascular Business Magazine.
To view the whole edition please click on the link below.

CVB April Edition

31
Mar

Cardiovascular Business (CVB) focuses on the business and economics behind the foremost clinical, interventional, and surgical and information technologies as well as pharmaceuticals and related products that are key to achieving a successful integrated cardiovascular practice.

The Attrius is highlighted in the... Read More

16
Mar

Industry News - Covidien to produce Technetium-99

The FDA has given Covidien permission to manufacture the medical isotope technetium-99 at its facility in Marland Heights, Mo. Covidien will use molybdenum-99 from South African firm Nuclear Energy to produce the rare isotope.

15
Mar

Industry News - PET Radiopharmaceutical Trial

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design and planned analysis of a Phase 3 clinical trial for the assessment of myocardial perfusion... Read More

11
Mar

Investor relationships

Positron announces that CSIR Group LLC, the Company’s investor relations firm, is currently working on a more robust investor community outreach campaign and assisting in adding value to Positron’s website making it an informative central location for investors regarding industry news and investor information.  CSIR... Read More